Y-mAbs Therapeutics Inc. (YMAB)
NASDAQ: YMAB
· Real-Time Price · USD
5.10
0.14 (2.82%)
At close: Jun 05, 2025, 3:59 PM
5.10
0.00%
After-hours: Jun 05, 2025, 05:57 PM EDT
2.82% (1D)
| Bid | 4.45 |
| Market Cap | 230.95M |
| Revenue (ttm) | 88.66M |
| Net Income (ttm) | -28.23M |
| EPS (ttm) | -0.64 |
| PE Ratio (ttm) | -7.97 |
| Forward PE | -4.67 |
| Analyst | Buy |
| Ask | 5.1 |
| Volume | 115,880 |
| Avg. Volume (20D) | 260,761 |
| Open | 4.97 |
| Previous Close | 4.96 |
| Day's Range | 4.78 - 5.12 |
| 52-Week Range | 3.55 - 16.11 |
| Beta | 0.51 |
About YMAB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol YMAB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for YMAB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
-0.77%
Y-MAbs Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
9 months ago
+10.63%
Y-mAbs Therapeutics shares are trading. The stock may be rebounding after falling earlier in the week on weak earnings and guidance.
3 weeks ago · seekingalpha.com
Y-mAbs Therapeutics, Inc. (YMAB) Q1 2025 Earnings Call TranscriptY-mAbs Therapeutics, Inc. (NASDAQ:YMAB ) Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ET Company Participants Courtney Dugan - Vice President, Head of Investor Relations Michael Rossi - Presi...
